News
Mimesis is a new Avicenna member!
We are truly delighted to welcome Mimesis as a new Avicenna member! Mimesis is an innovative start-up, founded in 2020 as a spinoff of the University of Catania, which offers to the biomedical industry and pharmaceutical companies the first generation of in Silico solutions.
Shiny Martis is the new Pharmaceutical Strategy TF Co-Chair
We are delighted to welcome Shiny Martis as the new Pharmaceutical Strategy TF Co-Chair. Shiny is Academic Partnership and Customer Success Scientist at Nova Discovery and is taking the lead of the TF together with Cécile De Coster.
Numalogics is a new Avicenna member
We are honored to welcome Numalogics as a new Avicenna’s member! Numalogics is a Montréal-based privately held company priding itself on its world-class biomechanical simulation expertise founded in 2010.
Working Group Leaders Elections - New Leaders
We are delighted to welcome Cécile Rousseau and Martha De Cunha who have been elected as new Working Group Leaders of the Avicenna's In Silico Application Working Group and Policy Development Working Group respectively.
New In Silico Application (ISA) Working Group
The new Avicenna In Silico Application Working Group, led by Cecile Rousseau, PhD (VCLS) and Emmanuelle Voisin, PhD (VCLS), aims to deploy In Silico methods downstream and design comprehensive solutions to allow any organization to time and cost effectively adopt and deploy in silico methods all along the development, registration and life cycle of the products.
Working Group Leaders elections
Our warmest congratulations to Liesbet Geris and Mark Palmer for their reappointment as Working Group Leaders of the Avicenna's Research & Technology Working Group and International Affairs Working Group respectively.